NCT02831660View on ClinicalTrials.gov

CU Programme of Idarucizumab for Japanese Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1

Participants

Timeline

Start Date

July 22, 2016

Primary Completion Date

September 16, 2016

Study Completion Date

September 16, 2016

Conditions
Hemorrhage
Interventions
DRUG

idarucizumab

Trial Locations (1)

816-0864

Fukuoka Tokushukai Medical Center, Fukuoka, Kasuga

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY